ArticleAddiction (Abingdon, England)2025
Alcohol and drug use and attainment of pregnancy preferences in the southwestern United States: A longitudinal cohort study.
Article in Addiction (Abingdon, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Alcohol and drug use and attainment of pregnancy preferences in the southwestern United States: A longitudinal cohort study.Addiction (Abingdon, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
aimsAddressing design and measurement limitations of prior studies, we examined whether individuals who use alcohol or drugs are less likely to attain their pregnancy preferences over one year.
designLongitudinal cohort study.
settingFive southwestern US states.
participants2015 individuals ages 15-34 years, capable of pregnancy and non-pregnant at enrollment from 23 primary and reproductive healthcare facilities (2019-2022). MEASUREMENTS: Data were collected over 13.5 months. Past-month alcohol, cannabis and other drug use were self-reported at baseline; prospective pregnancy preferences (prior to pregnancy) were reported quarterly using the Desire to Avoid Pregnancy (DAP) scale (range 0-4, 4 representing higher desire to avoid pregnancy); and incident pregnancy was reported every 6 weeks. We used adjusted mixed effects linear regression models to assess associations between baseline substance use and quarterly DAP scores and Cox proportional hazard models to investigate differential attainment of pregnancy preferences by substance use.
findingsAt baseline, 40% (795/1968) of participants reported drinking heavily, 16% (308/1968) reported cannabis use and 3% (53/1968) reported other drug use. Heavy (vs. moderate, low or no) drinking and daily cannabis (vs. no use) were associated with higher desire to avoid pregnancy [coefficient = 0.06, 95% confidence interval (95% CI) = 0.01-0.12], P = 0.02; coefficient = 0.14, 95% CI = 0.07-0.22, P < 0.001], but DAP scores did not differ by other drug use (coefficient = 0.13, 95% CI = -0.07 to 0.33, P = 0.21). 282 participants reported incident pregnancies; of these, 46% (130/282), 29% (81/282) and 25% (71/282) were among participants with low, mid-range and high DAP scores. Among those with high DAP scores, heavy drinking was positively associated with pregnancy [adjusted hazard ratio (aHR) = 1.51, 95% CI = 1.12-2.04, P < 0.01]. Among those with low DAP scores, less than daily versus no cannabis use was associated with pregnancy (aHR = 1.64, 95% CI = 1.13-2.38, P = <0.01). Among those with mid-range DAP scores, heavy drinking was inversely associated with pregnancy (aHR 0.62, 95% CI = 0.42-0.90, P = 0.01). Other drug use was not associated with pregnancy regardless of DAP score.
conclusionsHeavy drinking, but not cannabis use or other drug use, appears to be associated with elevated pregnancy risk among those who most desire to avoid pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.